Group 1 - The core viewpoint of the news is that Huisheng Biological (300871.SZ) reported its Q3 2025 results, highlighting the current institutional ownership and changes in public fund holdings [1] - As of October 27, 2025, four institutional investors hold a total of 84.8498 million shares of Huisheng Biological, representing 41.94% of the total share capital, with a decrease of 1.06 percentage points compared to the previous quarter [1] - The only public fund that increased its holdings in this period is Wanji Zhongzheng 2000 Index Enhanced A, while 58 public funds did not disclose their holdings this quarter, including several from CITIC Securities [1] Group 2 - In terms of foreign investment, UBS AG is noted as an external institution that did not disclose its holdings in this period [2]
机构风向标 | 回盛生物(300871)2025年三季度已披露前十大机构持股比例合计下跌1.06个百分点